| H5N1 Vaccination With and Without AS03: Systems Biology Analysis (NCT01573312) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-24 |
| Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB) (NCT01404312) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-23 |
| Phase I Trial of a Single Dose of CRS3123 (NCT01551004) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-22 |
| The SCOUT Study: "Short Course Therapy for Urinary Tract Infections in Children" (NCT01595529) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-18 |
| Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin (NCT01571414) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-01 |
| Evaluating the Safety of and Immune Response to HIV-MAG DNA Vaccine With or Without Plasmid IL-12 Adjuvant Delivered Intramuscularly Via Electroporation Followed by VSV-gag HIV Vaccine Boost in Healthy, HIV-Uninfected Adults (NCT01578889) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-01 |
| Evaluating the Safety and Immune Response of a Prime-Boost HIV Vaccine Regimen in Healthy, HIV-Uninfected, Vaccinia-Naive Adults (NCT01571960) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection (NCT01482767) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Perceived Barriers to Patient Adherence After Pediatric Solid Organ Transplantation (NCT01370746) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Post-treatment Effects of Ivermectin (IVM) or Diethylcarbamazine (DEC) in Loiasis (NCT01593722) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Sanaria™ PfSPZ Challenge Vaccine (NCT01546389) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Lentiviral Gene Transfer for Treatment of Children Older Than 2 Years of Age With X-Linked Severe Combined Immunodeficiency (NCT03315078) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-04-01 |
| Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant (NCT01578317) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-03-20 |
| Staged Phase I/II Hepatitis C Prophylactic Vaccine (NCT01436357) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-03-06 |
| Evaluating the Safety and Immune Response of an H7N7 Vaccine in Healthy Adults (NCT01534468) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-03-01 |
| Quadrivalent HPV Vaccine to Prevent Anal HPV in HIV-infected Men and Women (NCT01461096) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-03-01 |
| Steroid Treatment for Hypereosinophilic Syndrome (NCT01524536) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-02-16 |
| Chloroquine for Malaria in Pregnancy (NCT01443130) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-02-01 |
| Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers (NCT01381744) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-02-01 |
| Influenza A 2009 H1N1 Challenge Study in Healthy Adults (NCT01646138) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-02-01 |
| Determining Risk in Latent Tuberculosis (NCT01571739) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-01-02 |
| Praziquantel-Pharmacokinetic Study (NCT01288872) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-01-01 |
| Apheresis to Obtain Plasma and White Blood Cells in Malies (NCT01511601) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-20 |
| HIV Accelerated Liver Disease in Uganda (NCT01524562) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-20 |
| A Study to Determine the Immunogenicity and Oral Tolerance to Keyhole Limpet Hemocyanin (KLH) (NCT01489956) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine (NCT01506570) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Evaluating the Immune Response to a rAd5 HIV Vaccine Administered in Three Different Ways in Healthy, HIV-Uninfected Adults (NCT01479296) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Chikungunya Virus Vaccine Trial in Healthy Adults (NCT01489358) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Seasonal Influenza DNA Vaccine Prime With Trivalent Inactivated Vaccine (TIV) Boost Compared to TIV Alone (NCT01498718) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-12-01 |
| Detoxified J5 Core Glycolipid/ Group B Meningococcal Outer Membrane Protein Vaccine for Gram-negative Bacterial Sepsis Administered With and Without Synthetic CPG Oligodeoxynucleotide 7909 Adjuvant (NCT01164514) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-11-01 |
| Atopic Dermatitis Research Network (ADRN) Influenza Vaccine Pilot (NCT01518478) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-11-01 |
| TMC207 +/- Rifabutin/Rifampin (NCT01341184) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-10-21 |
| Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine (NCT01443663) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-10-01 |
| Evaluating the Safety of and Immune Response to the VSV-Indiana HIV Vaccine in Healthy, HIV-Uninfected Adults (NCT01438606) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-10-01 |
| TIV and High Dose TIV in Subjects With Rheumatoid Arthritis (NCT01436370) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-10-01 |
| Assessment of Alterations in Immune Function During Pregnancy and Post Parturition (NCT01200979) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-30 |
| Experimental PfSPZ Vaccine in Adults Without Malaria (NCT01441167) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-14 |
| Experimental AD4-H5-VTN Vaccine in Healthy Volunteers (NCT01443936) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-14 |
| Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women (NCT01181323) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation (NCT01278745) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| Boceprevir Drug Combination for Hepatitis C Treatment in People With and Without HIV (NCT01443923) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation (NCT01436305) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations (NCT01430403) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| GS-7977 With Ribavirin for Hepatitis C (SPARE) (NCT01441180) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-09-01 |
| Screening Volunteers for Clinical Trials (NCT01375530) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-16 |
| Influenza Antiviral DAS-181-F04 in Healthy Adults (NCT01651494) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-12 |
| Admission and Management of Occupational or Other Exposures to Biodefense/Bioterrorism Agents or to Epidemic/Emerging Infectious Diseases (NCT01200953) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-04 |
| Evaluating the Safety and Immune Response to an HIV Vaccine Boost Following the Administration of Two HIV Vaccines, in HIV-Uninfected, Healthy Adults (Study Extension to HVTN 073/SAAVI 102) (NCT01423825) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine (NCT01436422) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C (NCT01428700) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| Registry for the Atopic Dermatitis Research Network (NCT01494142) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| Initial Study of Malaria Vaccine Pfs25-EPA/Alhydrogel(Registered Trademark) (NCT01434381) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children (NCT01459198) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| Asthma Phenotypes in the Inner City (NCT01383941) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| Research Study of ATG and Rituximab in Renal Transplantation (NCT01318915) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-07-25 |
| Screening for LID Clinical Studies Unit Healthy Volunteer Protocols (NCT01386424) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-07-20 |
| DAS181 in Patients With Parainfluenza (NCT01441024) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-07-14 |
| Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials (NCT01376726) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-07-01 |
| Training Protocol on the Natural History of Tuberculosis (NCT01212003) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-06-30 |
| Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) (NCT01086540) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-06-24 |
| Immune Responses to Two Experimental HIV Vaccines in Healthy Adults (NCT01386489) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-06-17 |
| Utility of MODS for Diagnosis of MDR-TB and Second-Line Antituberculous Drug Susceptibility Testing in Mali (NCT01381757) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-31 |
| Preventing the Spread of Malaria in Mali (NCT01360112) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-20 |
| Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants (NCT01828073) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-19 |
| Patients Treated for SCID (1968-Present) (NCT01346150) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-15 |
| A Longitudinal Systems Biological Analysis of Naturally Acquired Malaria Immunity in Mali (NCT01322581) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Extended Follow-Up After Islet Transplantation in T1D (NCT01369082) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Biomarkers of Cockroach Sublingual Immunotherapy 2 (NCT01380327) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| H5N1 Mix and Match With AS03 (NCT01317758) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Persistence of Oral Tolerance to Peanut (NCT01366846) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Phase 1 PK Study of XOMA 3AB (NCT01357213) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| H5N1 Mix and Match With MF59 (NCT01317745) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals (NCT00955006) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-05-01 |
| Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents (NCT01302847) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-20 |
| Interferon Responses in Eczema Herpeticum (NCT01429311) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Evaluating the Use of Oseltamivir for the Treatment of Influenza in Adults (NCT01314911) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru (NCT02630082) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Eosinophilic Esophagitis Databank (NCT01323803) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Topical Metronidazole and Miconazole Co-formulated Vaginal Suppositories for Preventing Vaginal Infections in HIV-seronegative Women (NCT01230814) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-04-01 |
| Study of Effects of Tenofovir on Bone Health and Kidneys During Pregnancy and Breastfeeding (NCT01066858) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-22 |
| Viral Infections in Healthy and Immunocompromised Hosts (NCT01306084) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-15 |
| Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules (NCT01266850) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected Adults (NCT01266616) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Inducing Remission in Type 1 Diabetes With Alefacept (NCT00965458) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy (NCT01292070) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Tenofovir Gel in Pregnancy and Lactation (NCT01136759) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries (NCT01061151) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Long-Term Effects of Sublingual Grass Therapy (NCT01335139) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients (NCT01289717) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-03-01 |
| Oral Urea Breath Testing for Diagnosis and Treatment Response in Pulmonary Tuberculosis (NCT01301144) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-02-13 |
| Phase I STEBVax in Healthy Adults (NCT00974935) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-02-01 |
| Studies of Disorders With Increased Susceptibility to Fungal Infections (NCT01222741) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-01-07 |
| Antigenic Competition in HIV Preventive Vaccines (NCT01159990) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-01-01 |
| Evaluation of the Safety and Immunogenicity of a Live Attenuated Human Metapneumovirus Vaccine (NCT01255410) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-01-01 |
| The Role of Epigenetics in Inner City Asthma (NCT01382836) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-01-01 |
| Malaria Surveillance in Rakai, Uganda (NCT01265407) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-12-22 |
| Evaluation of Influenza-Specific Immune Responses in Children and Adults During the 2010-2011 Influenza Season in the U.S. (NCT01262079) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-12-01 |
| Safety and Efficacy of Investigational Anti-Influenza Immune Plasma in Treating Influenza (NCT01052480) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-12-01 |
| Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children (NCT01254175) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-12-01 |
| Searching for Persistence of Infection in Lyme Disease (NCT01143558) | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-11-04 |